News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,827 Results
Type
Article (2604)
Company Profile (41)
Press Release (38182)
Section
Business (15037)
Career Advice (85)
Deals (2250)
Drug Delivery (8)
Drug Development (4340)
Employer Resources (13)
FDA (458)
Job Trends (858)
News (21478)
Policy (1152)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (167)
Allergies (4)
Alliances (3722)
ALS (5)
Alzheimer's disease (50)
Antibody-drug conjugate (ADC) (14)
Approvals (459)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (568)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (31)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (19)
Cancer (147)
Cardiovascular disease (8)
Career advice (72)
Career pathing (1)
CAR-T (15)
Cell therapy (44)
Cervical cancer (3)
Clinical research (3358)
Collaboration (100)
Compensation (44)
COVID-19 (196)
CRISPR (7)
C-suite (26)
Cystic fibrosis (2)
Data (113)
Denatured (3)
Depression (3)
Diabetes (11)
Diagnostics (508)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (14)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4628)
Editorial (3)
Employer branding (2)
Employer resources (11)
Events (6423)
Executive appointments (88)
FDA (508)
Featured Employer (5)
Funding (76)
Gene editing (14)
Gene therapy (17)
GLP-1 (63)
Government (178)
Guidances (1)
Healthcare (872)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (203)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (12)
Interviews (7)
IPO (1063)
IRA (7)
Job creations (300)
Job search strategy (69)
Kidney cancer (4)
Labor market (3)
Layoffs (42)
Leadership (1)
Legal (224)
Liver cancer (6)
Lung cancer (16)
Lymphoma (3)
Management (4)
Manufacturing (21)
MASH (4)
Medical device (379)
Medtech (379)
Mergers & acquisitions (1251)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (95)
NextGen: Class of 2025 (386)
Non-profit (203)
Northern California (351)
Now hiring (4)
Obesity (16)
Opinion (21)
Ovarian cancer (11)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (21)
Patient recruitment (4)
Peanut (1)
People (5861)
Pharmaceutical (5)
Phase I (1453)
Phase II (1664)
Phase III (898)
Pipeline (79)
Podcasts (4)
Policy (12)
Postmarket research (34)
Preclinical (612)
Press Release (2)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (14)
Rare diseases (25)
Real estate (447)
Recruiting (6)
Regulatory (874)
Reports (6)
Research institute (157)
Resumes & cover letters (9)
RSV (1)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (341)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (506)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
United States (1740)
Vaccines (35)
Venture capitalists (7)
Webinars (3)
Weight loss (11)
Women's health (1)
Worklife (2)
Date
Today (8)
Last 7 days (65)
Last 30 days (247)
Last 365 days (2776)
2025 (694)
2024 (2830)
2023 (3110)
2022 (4085)
2021 (4388)
2020 (3731)
2019 (2409)
2018 (1826)
2017 (1949)
2016 (1747)
2015 (1956)
2014 (1426)
2013 (1235)
2012 (1431)
2011 (1370)
2010 (1204)
Location
Africa (49)
Alabama (1)
Arizona (15)
Asia (2085)
Australia (328)
California (800)
Canada (143)
China (40)
Colorado (22)
Connecticut (10)
Delaware (3)
Europe (4323)
Florida (48)
Georgia (8)
Idaho (5)
Illinois (16)
India (1)
Indiana (39)
Japan (8)
Kansas (13)
Maryland (27)
Massachusetts (296)
Michigan (8)
Minnesota (15)
Missouri (5)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (81)
New York (51)
North Carolina (89)
Northern California (351)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (53)
Rhode Island (2)
South America (54)
South Carolina (1)
Southern California (341)
Tennessee (3)
Texas (73)
Utah (3)
Virginia (8)
Washington D.C. (1)
Washington State (46)
Wisconsin (7)
40,827 Results for "pillar biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GenomOncology and Pillar Biosciences Announce Co-Marketing Partnership to Advance Rapid Precision Oncology Solutions
February 14, 2025
·
3 min read
Press Releases
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
March 12, 2025
·
8 min read
FDA
Pillar Biosciences oncoReveal™ CDx pan-cancer solid tumor IVD now FDA approved for general tumor profiling on the Illumina MiSeq™ Dx System
Pillar Biosciences, Inc., the leader in Decision Medicine™ today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) supplement application for its oncoReveal™ CDx pan-cancer solid tumor in vitro diagnostic (IVD).
April 23, 2024
·
3 min read
Lone Star Bio
Pillar Clinical Research Expands Leadership Team with the Addition of Zach Mitchell as Chief Commercial Officer
Pillar Clinical Research, a multi-specialty clinical research site network, has announced the appointment of Zach Mitchell as Chief Commercial Officer.
June 26, 2024
·
2 min read
Genetown
Pillar Biosciences to Present at NYBIO | NYSE Life Science Company Showcase on December 14th
Pillar Biosciences is pleased to announce that Randy Pritchard , Chief Executive Officer, and Vincent Ricci , Chief Financial Officer, will be presenting at the NYBIO | NYSE Life Science Company Showcase on December 14th.
December 7, 2023
·
2 min read
Genetown
Pillar Biosciences to Present New Scientific Data at Association for Molecular Pathology Annual Meeting
Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced the company and scientific collaborators will collectively present eleven studies and two corporate workshops at the 2023 Association for Molecular Pathology (AMP) Annual Meeting from November 14 -18, 2023 in Salt Lake City, UT (Booth #619).
November 8, 2023
·
3 min read
Business
Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
Illumina Inc. and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar’s suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
July 25, 2023
·
4 min read
Business
Pillar Biosciences and KeyGene Enter into Licensing Agreement
Pillar Biosciences, Inc. today announced a non-exclusive licensing agreement with Keygene N.V. related to their patent family entitled Combinatorial sequence barcodes for high throughput screening for use in Pillar Biosciences products, kits or services used for research or clinical testing.
April 13, 2023
·
3 min read
Genetown
Pillar Biosciences Launches oncoReveal™ Core LBx, an NGS Kit to Enable Localized Liquid Biopsy Testing
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the global launch of oncoReveal ™ Core LBx, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to enable laboratories with a solution for liquid biopsy-based pan-cancer tumor profiling.
September 19, 2023
·
3 min read
Genetown
Pillar Biosciences Receives College of American Pathologists (CAP) Accreditation
Pillar Biosciences, Inc. today announced their receipt of the College of American Pathologists (CAP) Accreditation for its CLIA certified reference lab.
February 7, 2023
·
3 min read
1 of 4,083
Next
